Related Experiment Video
Updated: Jan 30, 2026
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives
Tabata T França1, Lucila A Barreiros1, Basel K Al-Ramadi2
1a Department of Immunology, Institute of Biomedical Sciences , University of São Paulo , São Paulo , Brazil.
Insights
CD40 ligand (CD40L) deficiency causes severe immunodeficiency, leading to life-threatening infections. New research suggests impaired T cell and innate immune responses contribute, necessitating novel therapeutic strategies beyond current treatments.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- CD40 ligand (CD40L) deficiency, also known as X-linked Hyper-IgM syndrome, is a severe primary immunodeficiency.
- Mutations in the CD40L gene impair immune function, leading to high susceptibility to infections and poor long-term survival in affected patients.
Purpose of the Study:
- To review the clinical and immunological characteristics of CD40L deficiency.
- To discuss current therapeutic strategies and their limitations.
- To explore potential new treatment avenues based on a deeper understanding of CD40L function.
Main Methods:
- Literature review of clinical and immunological data on CD40L deficiency.
- Analysis of current treatment outcomes, including hematopoietic stem-cell transplantation, immunoglobulin replacement, G-CSF, and prophylactic antibiotics.
- Discussion of emerging research on CD40L's role in innate immunity.
Main Results:
- Despite existing therapies, CD40L-deficient patients face significant morbidity and mortality from infections.
- Susceptibility to opportunistic pathogens may stem from impaired T cell and innate immune responses, not solely B cell defects.
- CD40L-CD40 interactions appear crucial in early innate immune system development.
Conclusions:
- Current treatments for CD40L deficiency are insufficient to prevent life-threatening infections.
- A comprehensive understanding of CD40L's role in both adaptive and innate immunity is critical for improving patient outcomes.
- Novel gene therapies and redirected immunotherapies hold promise for reducing morbidity and mortality in CD40L-deficient individuals.
Introduction:
CD40 ligand (CD40L) deficiency or X-linked Hyper-IgM syndrome is a severe primary immunodeficiency caused by mutations in the CD40L gene. Despite currently available treatments, CD40L-deficient patients remain susceptible to life-threatening infections and have poor long term survival. Areas covered: Here, we discuss clinical and immunological characteristics of CD40L deficiency as well as current therapeutic strategies used for patient management. This review highlights that beyond B cell defects, patients' susceptibility to opportunistic pathogens might be due to impaired T cell and innate immune responses. In this context, we discuss how better knowledge of CD40L function and regulation may result in the development of new treatments. Expert opinion: Despite the introduction of hematopoietic stem-cell transplantation, immunoglobulin replacement, granulocyte colony-stimulating factor (G-CSF) administration, and prophylactic antibiotic therapies, life-threatening infections still cause high morbidity and mortality among CD40L-deficient patients. The reasons for this inadequate response to current therapies remains poorly understood, but recent reports suggest the involvement of CD40L-CD40 interaction in early stages of the innate immune system ontogeny. The development of novel gene therapeutic approaches and the use of redirected immunotherapies represent alternative treatment methods that could offer reduced morbidity and mortality rates for patients with CD40L deficiency.
Related Concept Videos
01:24Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
02:40Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:51Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
00:49Ligand Binding and Linkage
01:27Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
01:30Social Cognitive Perspective on Personality